Published in Sci Rep on August 18, 2015
Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement. Int J Mol Sci (2015) 0.82
Enhancement of 5-aminolevulinic acid-based fluorescence detection of side population-defined glioma stem cells by iron chelation. Sci Rep (2017) 0.79
Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations. Front Pharmacol (2016) 0.78
Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms. Sci Rep (2017) 0.75
Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response. Oncotarget (2016) 0.75
Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression. Biol Open (2017) 0.75
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol (2006) 11.56
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A (2002) 2.79
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther (2002) 2.60
Cell biology of heme. Am J Med Sci (1999) 2.51
Genetic and phenotypic diversity in breast tumor metastases. Cancer Res (2014) 1.96
Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res (2004) 1.82
ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy. Cancer Biol Ther (2005) 1.79
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol (2012) 1.65
Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine. Am J Pathol (2013) 1.24
The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clin Cancer Res (2007) 1.21
Triple-negative breast cancer and the need for new therapeutic targets. Am J Pathol (2013) 1.15
Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett (2012) 1.08
Breast cancer, side population cells and ABCG2 expression. Cancer Lett (2012) 1.07
Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J (2007) 1.01
Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications. J Surg Res (2013) 1.00
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B (2006) 0.93
Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid. Br J Cancer (2001) 0.90
Dual-channel red/blue fluorescence dosimetry with broadband reflectance spectroscopic correction measures protoporphyrin IX production during photodynamic therapy of actinic keratosis. J Biomed Opt (2014) 0.90
Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation. PLoS One (2012) 0.86
Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. Br J Cancer (2004) 0.86
Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation. Br J Cancer (2005) 0.84
Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy. J Photochem Photobiol B (2011) 0.83
The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells. Lasers Surg Med (2012) 0.83
Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes. J Biomed Opt (2010) 0.82
Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition. J Photochem Photobiol B (2013) 0.80
Vitamin D enhances the efficacy of photodynamic therapy in a murine model of breast cancer. Cancer Med (2015) 0.79
Modulation of PPIX synthesis and accumulation in various normal and glioma cell lines by modification of the cellular signaling and temperature. Lasers Surg Med (2013) 0.78
Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy. Photochem Photobiol (2015) 0.78